🦋 Hyperthyroidism Treatment Choice (Graves)
This tool gives the preferred treatment modality for Graves hyperthyroidism — antithyroid drugs, radioiodine, or surgery — based on pregnancy, goiter size/severity, malignancy, ATD failure, eye disease, and age.
Hyperthyroidism Treatment Choice (Graves)
Pregnancy
Severity/goiter
Suspected/coexisting thyroid malignancy or coexisting hyperparathyroidism needing surgery
ATD failure/relapse after proper treatment or severe adverse reaction
Moderate-severe active Graves orbitopathy
Child/adolescent
When to use
Use to direct modality choice: ATD for pregnancy/children/mild disease, surgery for large/compressive goiter or malignancy, and radioiodine or surgery for ATD failure (with eye-disease cautions for radioiodine).
How it works
Branch logic by patient features → ATD (MMI preferred; PTU in first trimester/storm/severe), surgery (large goiter, malignancy, hyperparathyroidism), or ¹³¹I (ATD failure/relapse; cautious in active orbitopathy and contraindicated in pregnancy).
Key points
- Radioiodine is contraindicated in pregnancy/lactation and can worsen moderate-severe active Graves orbitopathy, favoring surgery or ¹³¹I with glucocorticoid cover. (original synthesis · not guideline verbatim)
- During ATD, monitor liver function and white-cell count for agranulocytosis; β-blockers give symptomatic relief.
- All three modalities have trade-offs in cure rate, relapse, and resulting hypothyroidism, so choice is individualized with patient preference.
References
- Ross DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism. Thyroid 2016.
- Chinese guideline / consensus for the management of Graves hyperthyroidism (primary care 2019).
Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.